Somerset 321 Orchard Road #07-07 | WHATSAPP (65) 8011 1811 | Ngee Ann City Tower B #08-05A | WHATSAPP (65) 8712 0888
| Summary REEPOT is a 532 nm Q-switched Nd: YAG laser used for selected superficial pigmentation, including solar lentigines. The treatment uses targeted laser energy and cooling features to treat pigment while limiting unnecessary heat to nearby skin. Some solar lentigines may improve after one treatment, but the required number of sessions varies. Temporary redness, darkening, crusting, post-inflammatory hyperpigmentation and hypopigmentation are possible. A doctor must first confirm that the brown spot is suitable for laser treatment. REEPOT is not designed to treat every type of pigmentation, including all cases of melasma or deeper dermal pigment.ย |
Brown spots are among the most common signs of cumulative sun exposure and skin ageing. While laser treatment has been used for removal of pigmented spots for many years, some pigmentation, in particular solar lentigines (sun or age spots) can be surprisingly resistant to topical treatments and repeated โbrighteningโ procedures.
REEPOT is a 532 nm Q-switched Nd: YAG laser system used for selected superficial pigmented lesions, including solar lentigines. It incorporates the VSLS approach and contact-cooling features intended to improve targeting and protect surrounding skin.
Examples of solar lentigines: flat, well-defined brown patches commonly occurring on sun-exposed areas such as the face, hands and forearms.
REEPOT is primarily used for selected superficial or epidermal pigmentation. It may be considered for well-defined solar lentigines after a doctor has assessed the lesion and confirmed that laser treatment is appropriate.
Solar lentigo is a benign pigmented condition associated with long-term sun exposure. Lentigines are usually flat, brown patches with relatively well-defined borders and occur predominantly on chronically sun-exposed skin.
Importantly, not every brown spot is a lentigo. Melasma, post-inflammatory hyperpigmentation, seborrhoeic keratoses and melanocytic lesions can look similar but require different management.

REEPOT uses a 532 nm wavelength, which is strongly absorbed by melanin and therefore particularly suitable for superficial epidermal pigment.
What differentiates REEPOT from a conventional 532 nm Q-switched laser is its VSLS (Vasculature Salvage Laser Surgery) technology, which incorporates contact cooling and selective targeting of pigmented areas. The system also incorporates AutoDerm, which uses a camera-based recognition system to identify and track pigmented areas so that laser energy can be directed specifically at the target.
The rationale is straightforward: deliver sufficient energy to the pigment while minimising unnecessary injury to the surrounding skin.
This is particularly useful when treating patients with a greater tendency toward post-inflammatory hyperpigmentation (PIH).
It is important to emphasise that there is no single laser that is universally superior for every type of pigmentation. Treatment choice depends on the depth and type of pigment, skin phototype, lesion characteristics and previous treatments.
| Treatment | Typical number of treatments | Efficacy for treatment of pigmentation | Potential side effects | Limitations |
| REEPOT 532 nm Q-switched Nd: YAG | Often 1, sometimes 1โ2 | High potential for well-defined lentigines; early evidence includes complete clearance after a single treatment. | Temporary redness, darkening/crusting, PIH or hypopigmentation | 532nm light cannot penetrate deeper layers of the skin. Dermal pigmentation will need other types of laser treatment. |
| Conventional Q-switched Nd: YAG | Often multiple sessions depending on lesion | Preferred for smaller epidermal lesions like freckles. Larger patches may require multiple sessions. 1064 nm laser setting can treat deeper dermal pigments like melasma. | Discomfort, temporary redness, darkening/crusting, PIH or hypopigmentation | Less selective treatment of surrounding tissue; PIH remains an important concern |
| Picosecond laser | Often multiple sessions depending on lesion | Higher peak power of picosecond devices would benefit clearance of pigmentation, including dermal pigmentation, but is practically similar to conventional Q-switched lasers | Discomfort, temporary redness, darkening/crusting, PIH or hypopigmentation | Less selective treatment of surrounding tissue; PIH remains an important concern |
| IPL / BBL | Usually several sessions | Good for diffuse photodamage, freckles and mixed pigmentation | Redness, swelling, blistering and PIH; less precise for individual lesions | Higher risk of PIH with darker skin tones typically seen in South-east Asians |
The first step is determining exactly what type of pigmentation is being treated. The doctor assesses the colour, borders, distribution and depth of the pigmentation and considers factors such as skin type and previous laser treatments.
The skin is cleansed, and clinical photographs may be taken for comparison. The doctor may mark the treatment area before applying the clinicโs cooling or protective preparation.
Whether topical numbing is needed depends on the treatment area, lesion and individual sensitivity. Contact cooling may improve comfort, but it does not guarantee that numbing will be unnecessary for every patient.
After skin preparation and contact cooling, the REEPOTโs AutoDerm system will identify and map out the pigmented lesion based on the marking done earlier.
A series of shots will then be fired, which will fragment the melanin in the lesion.
Patients may feel a series of brief snapping or warm sensations during treatment.
Depending on the treatment protocol and location, a hydrocolloid or healing dressing is usually applied over the treated spots.
Immediately after treatment, the spots will appear darker, with mild redness or swelling. Over the following days, a fine crust or scab may develop as the treated pigment is eliminated. This typically separates naturally over approximately 10-14 days, although healing varies between individuals and treatment areas.
Though the protective dressing is waterproof, direct contact with water should be avoided to prevent premature peeling/dropping of the dressing.
If this happens, the patient should return to the clinic for reapplication of the dressing.
Our clinic will schedule an appointment for the dressing to be removed by the doctor 2 weeks after the procedure.
The treated area may appear slightly pale, or contain small blood vessels as it is still healing. After healing, the treated area will then return to the colour of surrounding skin.
Sun protection is arguably the most important part of the treatment. Use a broad-spectrum SPF 50+ sunscreen and minimise direct sun exposure during healing. UV exposure can contribute to recurrence and increases the risk of post-inflammatory pigmentation.
Patients are also encouraged to moisturise the treated area regularly.
REEPOT represents an interesting evolution of the traditional 532 nm Q-switched Nd: YAG approach to epidermal pigmentation. Its combination of a melanin-targeting wavelength with cooling and automated pigment targeting is designed to improve precision while reducing unnecessary thermal injury.
For patients with solar lentigines, this makes REEPOT an attractive treatment option, particularly when time is an important factor and patients cannot come for repeated treatments.
However, it should not be regarded as a universal replacement for conventional Q-switched or picosecond lasers. Especially when considering treatment of other pigmented conditions like melasma, PIH or other lesions that may exist in deeper layers of the skin.
The most important factor remains accurate diagnosis and appropriate treatment selection. When the pigment is correctly identified as an epidermal lesion such as a solar lentigo, the targeted Reepot treatment can provide substantial improvement.
People with medium to darker skin tones may have a higher tendency to develop PIH after inflammation or laser treatment. This does not automatically rule out REEPOT, but it makes diagnosis, conservative treatment planning, sun protection and follow-up particularly important.
The doctor may recommend a test spot, a modified treatment approach or an alternative treatment depending on the pigmentation and your previous response to procedures. PIH remains possible even when cooling and selective targeting are used.
REEPOT may substantially lighten or clear a treated solar lentigo, but no laser can prevent new pigmentation from developing. Continued ultraviolet exposure may contribute to recurrence or the appearance of new sun spots.
The outcome also depends on whether the original diagnosis was correct. Melasma, PIH and dermal pigmentation may respond differently and should not be managed as though they were solar lentigines.
Reepot Laser is available at Cambridge Medical (Somerset). Book a consultation with our doctors today for a treatment plan and pricing based on your skin.
Author: Dr Goh Yao Yu, Cambridge Medical (Somerset), Somerset, Singapore

Tel +65 6733 0777
SMS/Whatsapp +65 8712 0888
Mon to Fri 10am โ 7:30pm
Satย 10am โ 3pm
Sun and PHย Closed
Tel +65 6937 6977
SMS/Whatsapp +65 8011 1811
Mon to Fri 10am โ 7:30pm
Satย 10am โ 3pm
Sun and PHย Closed
Member of Beyond Medical Group
Copyright 2026 ยฉ Cambridge Medical Group (A subsidiary of Beyond Medical Group) | Terms & Conditions